M. Sano

Publications330
h-index82
Citations26,546
Highly Influential Citations960
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • Y. Stern
  • 778 Publications, 64,906 Citations
  • R. Mayeux
  • 697 Publications, 68,862 Citations
  • J. Morris
  • 695 Publications, 88,641 Citations
  • R. Petersen
  • 993 Publications, 123,851 Citations
  • Publications
  • Influence
An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease
We developed a set of informant-based items describing performance of activities of daily living (ADL) by patients with Alzheimer's disease (AD) to identify which ADL are useful for assessment of… Expand
  • 973
  • 78
Vitamin E and donepezil for the treatment of mild cognitive impairment.
BACKGROUND Mild cognitive impairment is a transitional state between the cognitive changes of normal aging and early Alzheimer's disease. METHODS In a double-blind study, we evaluated subjects with… Expand
  • 1,560
  • 59
  • PDF
Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease
The Alzheimer Disease Genetics Consortium (ADGC) performed a genome-wide association study of late-onset Alzheimer disease using a three-stage design consisting of a discovery stage (stage 1) and two… Expand
  • 1,385
  • 51
  • PDF
Cognitive impairment after stroke: frequency, patterns, and relationship to functional abilities.
Cognitive function was examined in 227 patients three months after admission to hospital for ischaemic stroke, and in 240 stroke-free controls, using 17 scored items that assessed memory,… Expand
  • 771
  • 34
  • PDF
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
BACKGROUND Mild cognitive impairment (MCI) represents a transitional state between the cognitive changes of normal aging and very early dementia and is becoming increasingly recognized as a risk… Expand
  • 810
  • 32
  • PDF
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
Frontotemporal lobar degeneration (FTLD) is the second most common cause of presenile dementia. The predominant neuropathology is FTLD with TAR DNA-binding protein (TDP-43) inclusions (FTLD-TDP).… Expand
  • 388
  • 29
  • PDF
Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs: Additions to the Alzheimer's Disease Assessment Scale That Broaden Its Scope
The cognitive assessment protocol of the Alzheimer's Disease Cooperative Study (ADCS) was designed to evaluate the reliability and validity of cognitive assessment measures that might be valuable… Expand
  • 457
  • 21
Quality of Life in Patients with Alzheimer's Disease as Reported by Patient Proxies
OBJECTIVE: To measure behaviors indicative of quality of life (QOL) in patients with Alzheimer's disease and to examine correlates of patient QOL.
  • 186
  • 20
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis
Pancreatitis is a complex, progressively destructive inflammatory disorder. Alcohol was long thought to be the primary causative agent, but genetic contributions have been of interest since the… Expand
  • 218
  • 19
  • PDF
Effect of literacy on neuropsychological test performance in nondemented, education-matched elders.
The current investigation compared neuropsychological test performance among nondemented literate and illiterate elders. The sample included participants in an epidemiological study of normal aging… Expand
  • 231
  • 19